NAYA NAYA Biosciences Inc: Return on Sales by Net Profit

Graphic logo of NAYA Biosciences (NAYA)

NAYA Biosciences (NAYA) prospects in gene modification and reproductive medicine are driving the current trend, while the company's sales margins demonstrate a new parameter -122.80. Growth is based on the closed patents of the FLEX-NK platform, although the market currently prices in the assets speculatively, awaiting management's success. Profitability analysis helps avoid overpaying for the stock during periods of hype.

NAYA Biosciences Corp (NAYA) - Net Margin from 07/04/2022 to 04/28/2025

Analytical breakdowns for NAYA Biosciences

Analysis of all company metrics:NAYA Biosciences Inc - NAYA
Manufactured product of NAYA Bio

Analyzing the efficiency of converting revenue into profit is critical for selecting the fundamental leaders of the sector. This metric measures the share of net income after deducting all operating expenses relative to total sales volume. For NAYA Biosciences (NAYA), which relies on external investments for antibody development, this calculation reveals the extent of its dependence on capital injections. By analyzing the history of net profit margins, an investor can uncover hidden business degradation in the absence of stable commercial products.

Main competitors

ONC: Net Sales Margin|Net Margin Halozyme Inc. (HALO)|Net Margin RevMed|Net Return on Sales AAPG (Ascentage Pharma Group)|Net Sales Margin CGON|UroGen Pharma - Net Return on Sales|Bicara Therapeutics - Return on Sales by Net Profit|Net Sales Margin Personalis Inc PSNL|Erasca Oncology - Net Sales Margin|Net Profit Rate DCTH (Delcath Corp)|YMAB: Net Sales Margin|AURA - Company Sales Margin|CADL (Candel Therapeutics Inc.) - Net Sales Margin|Net Return on Sales ARAY (Accuray)|Return on Sales by Net Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Net Margin|Net Margin Citius Oncology, Inc. CTOR|HURA - Return on Sales by Net Profit|protaratx.com - Net Sales Margin|FATE - Net Sales Margin|WHWK: Net Sales Margin|TScan Therapeutics (TCRX) - Net Sales Margin|Net Margin Champions Oncology|Net Margin XBIT|Net Sales Margin CVM|Return on Sales by Net Profit OS Therapies Inc. OSTX|Net Margin Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Net Margin|ANL - Net Margin|Net Margin verupharma.com|TPST: Net Sales Margin|XLO - Company Sales Margin|Net Margin Renovaro|Net Sales Margin muraloncology.com|Net Sales Margin KAPA|Company Sales Margin OnKure Therapeutics, Inc.|Net Sales Margin GDTC (w2.cytomed.sg)|CRIS - Return on Sales by Net Profit|Apollomics - Net Sales Margin|Tharimmune Corp (THAR) - Return on Sales by Net Profit|ADVB: Net Sales Margin|Return on Sales by Net Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Net Sales Margin|Net Return on Sales SBFM (Sunshine Biopharma)|Net Margin Xenetic Bio (XBIO)|Net Margin SLRX (Salarius Pharma)|Kitov Pharma - Return on Sales by Net Profit|American Oncology Network (AONC) - Net Margin|BeiGene - Net Sales Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Sales by Net Profit|ELEV (Elevation Oncology, Inc.) - Return on Sales by Net Profit|iCAD Inc. - Net Profit Rate|Return on Sales by Net Profit IKNA|Net Sales Margin notablelabs.com|Return on Sales by Net Profit VIRX (Viracta Therapeutics Inc.)|MOR - Net Margin|Net Sales Margin AAPGV (Ascentage)